Treatment success rate for patients treated for MDR-TB in Nepal
Nepal: Treatment success rate for patients treated for MDR-TB was 77.0% in 2022. ▲ Rising
Latest (2022)
77.0%
Change on year
unchanged
World rank
61st
of 163 countries
All-time high
77.0%
in 2021
All-time low
64.0%
in 2008
Years of data
16
2007–2022
Treatment success rate for patients treated for MDR-TB in Nepal, 2007–2022
Source: World Health Organization, Global Health Observatory.
Analysis
In 2022, treatment success rate for patients treated for mdr-tb in Nepal stood at 77.0%. That is the highest value across all 16 years on record.
The figure is up 1.3% over ten years.
Over the whole period, treatment success rate for patients treated for mdr-tb in Nepal peaked at 77.0% in 2021 and was at its lowest, 64.0%, in 2008.
Nepal ranks 61st of 163 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 16 years of available data.
Treatment success rate for patients treated for MDR-TB in Nepal, year by year
| Year | Value | Change |
|---|---|---|
| 2007 | 73.0% | — |
| 2008 | 64.0% | -12.3% |
| 2009 | 72.0% | +12.5% |
| 2010 | 75.0% | +4.2% |
| 2011 | 72.0% | -4.0% |
| 2012 | 76.0% | +5.6% |
| 2013 | 71.0% | -6.6% |
| 2014 | 70.0% | -1.4% |
| 2015 | 70.0% | +0.0% |
| 2016 | 68.0% | -2.9% |
| 2017 | 70.0% | +2.9% |
| 2018 | 75.0% | +7.1% |
| 2019 | 73.0% | -2.7% |
| 2020 | 75.0% | +2.7% |
| 2021 | 77.0% | +2.7% |
| 2022 | 77.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 69.7% | 64.0% | 73.0% | 3 |
| 2010s | 72.0% | 68.0% | 76.0% | 10 |
| 2020s | 76.3% | 75.0% | 77.0% | 3 |
Countries ranked near Nepal
- 59 Venezuela, Bolivarian Republic of 78.0% compare
- 59 Bangladesh 78.0% compare
- 61 Mozambique 77.0% compare
- 61 India 77.0% compare
- 64 Iraq 76.0% compare
- 64 Philippines 76.0% compare
- 64 Pakistan 76.0% compare
- 64 Guinea 76.0% compare
- 64 Lao People's Democratic Republic 76.0% compare
- 64 Nigeria 76.0% compare
More health data for Nepal
- Un projection of annual infant deaths, annual growth rate -1.95 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8518 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,326 deaths per 1,000 people (2090)
- Number of infants who die before age 1 955 deaths (2100)
- Population ages 50-54, male, annual growth rate 0.3625 % change on previous year (2025)
- Population ages 50-54, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 50-54, male, per capita 0.0213 units per person (2025)
- Population ages 55-59, female, annual growth rate 3.08 % change on previous year (2025)
- Population ages 55-59, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, female, per capita 0.0199 units per person (2025)
Frequently asked questions
- What is treatment success rate for patients treated for mdr-tb in Nepal?
- Treatment success rate for patients treated for mdr-tb in Nepal was 77.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate for patients treated for mdr-tb recorded in Nepal?
- The highest recorded value was 77.0% in 2021.
- What is the lowest treatment success rate for patients treated for mdr-tb recorded in Nepal?
- The lowest recorded value was 64.0% in 2008.
- How does Nepal rank for treatment success rate for patients treated for mdr-tb?
- Nepal ranks 61st out of 163 countries with data for 2022.
- Is treatment success rate for patients treated for mdr-tb rising or falling in Nepal?
- Over the last ten years it is up 1.3%. The long-run trend across the full record is rising.
- Where does this Nepal data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).